Dutapad 0.5mg Tablet
Prescription Required
Product introduction
Dutapad 0.5mg Tablet is used in the treatment of benign prostatic hyperplasia. It shrinks the size of the enlarged prostate gland to relieve symptoms like pain and difficulty in passing urine.
Dutapad 0.5mg Tablet is used to treat enlarged prostate gland in men
Dutapad 0.5mg Tablet is used to treat enlarged prostate gland in men
Uses of Dutapad Tablet
Benefits of Dutapad Tablet
In Benign prostatic hyperplasia
When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and the need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Dutapad 0.5mg Tablet works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. It also helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate. Take this medicine exactly as prescribed for maximum benefits.
Side effects of Dutapad Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Dutapad
- Decreased sperm count
- Impotence
- Decreased libido
- Ejaculation disorder
- Breast enlargement in male
- Breast tenderness in male
How to use Dutapad Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dutapad 0.5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Dutapad 0.5mg Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Dutapad 0.5mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
UNSAFE
Dutapad 0.5mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
$med_name is not indicated for use in women.
$med_name is not indicated for use in women.
Driving
SAFE
Dutapad 0.5mg Tablet does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Dutapad 0.5mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Dutapad 0.5mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Dutapad 0.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Dutapad 0.5mg Tablet may be needed. Please consult your doctor.
Use of Dutapad 0.5mg Tablet is not recommended in patients with severe liver disease.
Use of Dutapad 0.5mg Tablet is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Dutapad 0.5mg Tablet
βΉ9.0/Tablet
Dutacet 0.5mg Tablet
Kivi Labs Ltd
βΉ9.9/tablet
22% costlier
Veltride Tablet
Intas Pharmaceuticals Ltd
βΉ20.8/tablet
157% costlier
Dutaone Tablet
Rivan Pharma
βΉ10.6/tablet
31% costlier
Dute 0.5mg Tablet
Tetramed Biotek Pvt Ltd
βΉ12.5/tablet
54% costlier
Dutamax Tablet
Galcare Pharmaceutical Pvt Ltd
βΉ11/tablet
36% costlier
Quick tips
- Your doctor has prescribed Dutapad 0.5mg Tablet to shrink the enlarged prostate and reduce the risk of urinary retention.
- It may take 3 to 6 months to see the full beneficial effect of Dutapad 0.5mg Tablet. Hence, continue taking the medicine as advised by your doctor.
- Dutapad 0.5mg Tablet is usually well tolerated. However, it may produce some mild sexual side effects such as low sexual drive.
- Do not donate blood for 6 months after taking the last dose of Dutapad 0.5mg Tablet.
Fact Box
Chemical Class
Androgen Derivative
Habit Forming
No
Therapeutic Class
UROLOGY
Action Class
5 alpha- reductase inhibitor (5ARI)
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 723.
- Dutasteride. Research Triangle Park, North Carolina: GlaxoSmithKline; 2001 [revised Jun. 2008]. [Accessed 04 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
- Dutasteride [Product Monograph]. Mississauga, Ontario: GlaxoSmithKline Inc.; 2013. [Accessed 20 June 2023]. (online) Available from:
Marketer details
Name: Cannote Healthcare
Address: krishna park, 1st and 2nd floor, opposite nirman tower, ghatlodiya, ahmedabad, gujarat 380061
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
βΉ90
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT